THE-630 clinical trials

A Phase 1/2 Study of the Safety, Pharmacokinetics and Anti-Tumor Activity of the Oral KIT Inhibitor THE-630 in Patients with Advanced Gastrointestinal Stromal Tumors (GIST)

This study is testing a new medicine, THE-630, for people with a type of cancer called GIST. It's looking at how safe the medicine is, how it moves through the body, and if it helps shrink tumours. It's in early stages, checking different doses.